Ibrance 100 MG tablet 7S
Ended Awarded Last action
- Contract number
- SPE2DR26F6T4S
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,560
Award facts
- Contract value 100% obligated
- $8,559.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Ibrance 100 mg tablets in a seven-count configuration, with a ceiling value of $8,559.84 and firm fixed pricing. This is a non-set-aside competitive award with an ultimate completion date of December 19, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. The performance location is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania.
As a major pharmaceutical distributor and critical federal medical supply vendor, AmerisourceBergen supplies a comprehensive portfolio of pharmaceutical products to support military healthcare programs and other federal health systems. Ibrance, a cancer treatment medication, represents the type of specialized pharmaceutical products the company delivers under its DLA pharmaceutical prime vendor agreement. The contract demonstrates AmerisourceBergen's continued role in the Defense Logistics Agency's Medical Supply Chain, which provides essential medications and medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities worldwide.
Quick answers
Who was awarded contract SPE2DR26F6T4S?
SPE2DR26F6T4S was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 28, 2025.
How much is contract SPE2DR26F6T4S worth?
The government has obligated $8,560 on SPE2DR26F6T4S.
Is contract SPE2DR26F6T4S an order under another contract?
Yes. SPE2DR26F6T4S is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6T4S competed?
The extent of competition for SPE2DR26F6T4S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award